We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

191 hedge funds and large institutions have $3.81B invested in NEVRO CORP. in 2019 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 23

90% more call options, than puts

Call options by funds: $41.5M | Put options by funds: $21.9M

36% more capital invested

Capital invested by funds: $2.79B → $3.81B (+$1.02B)

22% more funds holding

Funds holding: 156191 (+35)

2% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 56

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
191
Holders Change
+35
Holders Change %
+22.44%
% of All Funds
3.76%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
60
Increased
57
Reduced
56
Closed
23
Calls
$41.5M
Puts
$21.9M
Net Calls
+$19.6M
Net Calls Change
+$49.9M
Name Holding Trade Value Shares
Change
Change in
Stake
PMAM
101
Picton Mahoney Asset Management
Ontario, Canada
$1.72M +$1.45M +14,600 New
Truist Financial
102
Truist Financial
North Carolina
$1.71M +$1.44M +14,578 New
State Board of Administration of Florida Retirement System
103
State Board of Administration of Florida Retirement System
Florida
$1.69M -$203K -2,050 -12%
UCFA
104
United Capital Financial Advisors
Texas
$1.66M -$53.4K -539 -4%
MIM
105
MetLife Investment Management
New Jersey
$1.53M
Envestnet Asset Management
106
Envestnet Asset Management
Illinois
$1.49M -$341K -3,444 -21%
SO
107
STRS Ohio
Ohio
$1.48M +$911K +9,200 +271%
RHJA
108
Rice Hall James & Associates
California
$1.47M -$1.08M -10,913 -47%
Royal Bank of Canada
109
Royal Bank of Canada
Ontario, Canada
$1.45M +$249K +2,513 +26%
BCM
110
Bayesian Capital Management
New York
$1.36M +$1.14M +11,541 New
Los Angeles Capital Management
111
Los Angeles Capital Management
California
$1.25M +$1.05M +10,612 New
OAM
112
Oppenheimer Asset Management
New York
$1.21M -$144K -1,454 -12%
TI
113
Trexquant Investment
Connecticut
$1.17M -$184K -1,853 -16%
Comerica Bank
114
Comerica Bank
Texas
$1.16M +$843K +8,517 New
AQR Capital Management
115
AQR Capital Management
Connecticut
$1.1M +$924K +9,332 New
MLICM
116
Metropolitan Life Insurance Company (MetLife)
New York
$1.09M -$41.1K -415 -4%
QT
117
Quantbot Technologies
New York
$1.07M +$905K +9,134 New
SCM
118
Soleus Capital Management
Connecticut
$969K +$817K +8,246 New
WG
119
Winton Group
United Kingdom
$955K -$217K -2,193 -21%
Citigroup
120
Citigroup
New York
$890K +$134K +1,349 +22%
GAM
121
Gotham Asset Management
New York
$776K +$654K +6,599 New
AB
122
Amalgamated Bank
New York
$642K +$23.9K +241 +5%
TC
123
TwinBeech Capital
New York
$628K +$529K +5,344 New
Nomura Holdings
124
Nomura Holdings
Japan
$598K +$152K +1,530 +43%
WA
125
Wealth Architects
California
$588K

NVRO Hedge Fund Activity: Q4 2019 in Review

191 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2019, worth a combined $3.81B — up 36% from $2.79B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new NVRO positions and 23 closed out — a net gain of 37 holders — while 57 added to existing stakes and 56 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $38.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $71.7M.

  • 191 institutional investors held NEVRO CORP. (NVRO) as of Q4 2019, up from 156 in Q3 2019.
  • Funds reported $3.81B of NEVRO CORP. stock for Q4 2019, up 36% quarter-over-quarter.
  • 60 funds opened new NEVRO CORP. positions in Q4 2019 and 23 closed out, a net change of +37 holders.
  • The largest NEVRO CORP. buyer in Q4 2019 was Victory Capital Management, an estimated $38.7M added.
  • The largest NEVRO CORP. seller in Q4 2019 was T. Rowe Price Associates, an estimated $71.7M sold.

Based on aggregated 13F filings for Q4 2019.